Table 2.

Response to eltrombopag in ITP patients

Variable	n (%) or median (range)	95% CIs
Time to response	35 days (28-50 days)
Cumulative incidence of overall response	48
At day-30 of Eltrombopag	22 (41.5%)	26.6-53.4%
At day-60 of Eltrombopag	37 (69.8%)	54.5-80%
At day-90 of Eltrombopag	43 (81.1%)	67-89.2%
Patients achieving complete response
At day-30 of Eltrombopag	9 (17%)	6.2-26.5%
At day-60 of Eltrombopag	14 (26.4%)	13.5-37.4%
At day-90 of Eltrombopag	18 (34%)	19.9-45.6
Time to relapse in days	not reached
Cumulative incidence of relapse	10
At 1-year	3 (6.6%)	0-13.6%
At 2-year	6 (15.3%)	3.1-26%
At 3-year	8 (25.3%)	6.7-41.1%
At 5-year	10 (47.7%)	8.5-70.1%